Insider buying
~$12K10K sh @ $1.20
Traded Dec 30, 2024 · filed 3 days later
The CEO of Prelude Therapeutics paid $12K out of pocket for Prelude Therapeutics shares. 2 other people at Prelude Therapeutics bought some too, in the same month. Shares held went up 8% with this purchase.
